Synthèse de l'Oméprazole pour les Inhibiteurs de la Pompe à Protons

Contrôle de l'acidité gastrique par chimie sélective chirale

Pharmaceutical & Drug Manufacturing Global Industrial Scale $3.5 billion

Aperçu

Omeprazole is the first proton pump inhibitor (PPI) to reach the market and remains one of the most prescribed medications globally for treating gastric acid disorders, peptic ulcers, and GERD. The synthesis involves a multi-step process building the benzimidazole-pyridine core structure. The chiral version, esomeprazole (the S-enantiomer), represents a significant pharmaceutical advancement, produced using an asymmetric oxidation that won AstraZeneca substantial patent protection.

Procédé chimique

2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.

Thioether intermediate + m-CPBA → Omeprazole (sulfoxide)
For esomeprazole: Ti(OiPr)₄/(R,R)-DET/cumene hydroperoxide → S-omeprazole (>99.5% ee)

Matières premières

  • 5-Methoxy-2-mercaptobenzimidazole — Multi-step synthesis from o-phenylenediamine (Core structure)
  • 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine — Pyridine chemistry (Pyridine moiety)
  • m-CPBA (meta-chloroperoxybenzoic acid) — Chemical synthesis (Oxidizing agent)

Produits finis

  • Omeprazole (C₁₇H₁₉N₃O₃S) — Proton pump inhibitor for GERD and ulcers (Racemic or enantiopure form)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.

Considérations de sécurité

Innovations récentes

Biocatalytic oxidation using engineered cytochrome P450 enzymes and Baeyer-Villiger monooxygenases offers enantioselective sulfoxidation under mild conditions, potentially replacing chemical oxidants entirely.

Échelle de production

800

tonnes/an

$3.5 billion

valeur marchande

Plus dans Pharmaceutical & Drug Manufacturing

Production de Pénicilline G par Fermentation

Global Industrial Scale

Production d'Insuline Humaine Recombinante

Global Industrial Scale

Production Semi-Synthétique d'Amoxicilline

Global Industrial Scale

Synthèse de l'Aspirine par Acétylation de l'Acide Salicylique

Global Industrial Scale

Synthèse de l'Ibuprofène — Procédé Vert BHC

Global Industrial Scale

Synthèse du Chlorhydrate de Metformine

Global Industrial Scale

Synthèse du Paracétamol (Acétaminophène)

Global Industrial Scale

Frequently Asked Questions

What industry uses Synthèse de l'Oméprazole pour les Inhibiteurs de la Pompe à Protons?
Synthèse de l'Oméprazole pour les Inhibiteurs de la Pompe à Protons is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in Synthèse de l'Oméprazole pour les Inhibiteurs de la Pompe à Protons?
2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.
What is the economic significance of Synthèse de l'Oméprazole pour les Inhibiteurs de la Pompe à Protons?
Synthèse de l'Oméprazole pour les Inhibiteurs de la Pompe à Protons has a market value of $3.5 billion and annual production of 800 tons.
What is the environmental impact of Synthèse de l'Oméprazole pour les Inhibiteurs de la Pompe à Protons?
Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.
What raw materials are used in Synthèse de l'Oméprazole pour les Inhibiteurs de la Pompe à Protons?
The main raw materials include: 5-Methoxy-2-mercaptobenzimidazole, 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine, m-CPBA (meta-chloroperoxybenzoic acid).